Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 26, 2025

Keywords

ClinConnect Summary

The ARRHYTHMIC GENE-HEART trial is studying how gene tests can help diagnose and treat patients with genetic heart diseases that cause abnormal heart rhythms, known as arrhythmias. This research is happening at the Cardiogenetic Center in Ferrara, Italy, where they aim to gather detailed information about patients who are suspected of having these conditions. By collecting data on patients' health, family history, and treatment outcomes, the study hopes to improve our understanding of these genetic issues and how they affect patients over time.

To be eligible for this study, participants should be patients who have been evaluated at the Cardiogenetic Center and have a confirmed genetic heart disease. If someone decides to join, they can expect to provide information about their health and family history, and they will be monitored over time to see how their condition progresses and how well different treatments work. It’s important to note that patients who do not have a genetic heart condition or who refuse to give consent will not be able to participate in this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
• • Having a proven cardiogenetic disease
• Exclusion Criteria:
• • Refuse to provide informed consents
• • Patients not having a cardiogenic disease